Target intelligence / Profile preview

Ribosomal protein L36 pseudogene 15 (RPL36P15)

Target
RPL36P15
Molecular classification
Other (Pseudogene)
01

Overview

RPL36P15 is a processed pseudogene corresponding to the ribosomal protein L36 gene (RPL36)[2][5]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they usually lack the ability to encode an active protein due to disabling mutations or gene truncation[4][8]. RPL36P15, like many ribosomal protein pseudogenes, is derived by retrotransposition from the functional RPL36 gene, which encodes a component of the large (60S) ribosomal subunit[1][3][4][8]. RPL36P15 does not code for a functional ribosomal protein and is not known to play a role in disease or cellular processes. It is one of many processed pseudogenes distributed throughout the human genome, reflecting the high retrotranspositional activity and gene duplication events involving ribosomal protein genes. No evidence indicates that RPL36P15 is transcribed into RNA or contributes to any biological pathway or disease state[2][4][8]. Key clarification: Although ribosomal protein L36 (RPL36) itself is involved in ribosome function and human disease[1][3], RPL36P15 is a noncoding pseudogene and should not be considered a receptor, enzyme, or bona fide molecular target for drug development[2][4][8]. If you require structured data for the functional protein RPL36, a different entry would be appropriate.

Other names
RPL36_6_1283RPL36P15
02

Biological functions

Other (Does not encode a functional protein; see description)
03

Disease associations

Other (No direct disease role reported)

Beyond the preview

Go deeper on Ribosomal protein L36 pseudogene 15 (RPL36P15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36 pseudogene 15 (RPL36P15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call